Madrigal Pharmaceuticals ... (MDGL)
NASDAQ: MDGL
· Real-Time Price · USD
364.16
-7.21 (-1.94%)
At close: Aug 15, 2025, 3:04 PM
Madrigal Pharmaceuticals Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 515.55M | 317.38M | 180.13M | 77.58M | 15.41M | 770K | 770K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | 19.55M | 11.01M | 6.67M | 3.37M | 1.35M | 571K | 527K | 514K | 500K | 484K | 467K | 444K | 420K | 399K | 405K | 299K | 202K | 113K |
Gross Profit | 496.43M | 306.81M | 173.9M | 73.45M | 13.29M | -571K | -527K | -514K | -500K | -484K | -467K | -444K | -420K | -399K | -405K | -299K | -202K | -113K |
Operating Income | -309.81M | -425.15M | -497.87M | -548.05M | -530.28M | -454.2M | -380.5M | -348.62M | -330.5M | -314.32M | -293.43M | -272.74M | -255.48M | -246.95M | -242.48M | -237.44M | -233.06M | -221.65M |
Interest Income | 41.7M | 47.69M | 46.65M | 44.53M | 34.81M | 24.14M | 19.58M | 11.7M | 9.12M | 5.89M | 2.19M | 1.16M | 504K | 272K | 363K | 743K | 1.51M | 2.62M |
Pretax Income | -281.9M | -391.59M | -465.89M | -518.67M | -510.45M | -444.27M | -373.63M | -347.34M | -329.8M | -314.73M | -295.35M | -273.99M | -255.9M | -246.82M | -241.85M | -236.42M | -231.28M | -218.66M |
Net Income | -281.9M | -391.59M | -465.89M | -518.67M | -510.45M | -444.27M | -374.53M | -349.92M | -332.38M | -318.09M | -297.88M | -274.84M | -256.75M | -246.89M | -241.85M | -236.42M | -231.28M | -218.66M |
Selling & General & Admin | 613.54M | 522.13M | 435.06M | 340.37M | 260.37M | 172.76M | 108.15M | 76.17M | 60.73M | 54.65M | 48.13M | 45.28M | 41.43M | 39.77M | 37.32M | 31.73M | 28.94M | 24.47M |
Research & Development | 192.27M | 209.39M | 236.28M | 281.13M | 283.34M | 281.12M | 272.21M | 272.45M | 269.77M | 259.67M | 245.44M | 227.59M | 214.19M | 207.32M | 205.16M | 205.7M | 204.12M | 197.18M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 273K | 273K | 273K | 373K |
Operating Expenses | 806.24M | 731.95M | 671.77M | 621.5M | 543.71M | 453.89M | 380.35M | 348.62M | 330.5M | 314.32M | 293.57M | 272.87M | 255.62M | 247.09M | 242.48M | 237.44M | 233.06M | 221.65M |
Interest Expense | 13.74M | 14.13M | 14.67M | 15.14M | 14.97M | 14.21M | 12.71M | 10.42M | 8.42M | 6.3M | 3.96M | 2.28M | 780K | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | -152.61M | -152.61M | -152.61M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 825.36M | 742.53M | 678.01M | 624.87M | 544.92M | 454.2M | 380.5M | 348.62M | 330.5M | 314.32M | 293.57M | 272.87M | 255.62M | 247.09M | 242.48M | 237.44M | 233.06M | 221.65M |
Income Tax Expense | n/a | n/a | n/a | 98.19K | -36.81K | -36.81K | 859.19K | 2.44M | 2.58M | 3.36M | 2.53M | 743K | 743K | -37K | -266K | -276K | -276K | -276K |
Shares Outstanding (Basic) | 22.21M | 22.09M | 21.27M | 21.75M | 21.4M | 20M | 19.76M | 18.48M | 18.31M | 18.19M | 17.24M | 17.1M | 17.1M | 17.1M | 17.07M | 16.64M | 16.57M | 15.84M |
Shares Outstanding (Diluted) | 22.21M | 22.09M | 21.27M | 21.75M | 21.4M | 20M | 19.76M | 18.48M | 18.31M | 18.19M | 17.24M | 17.1M | 17.1M | 17.1M | 17.07M | 16.64M | 16.57M | 15.84M |
EPS (Basic) | -12.64 | -17.84 | -21.9 | -25.08 | -25.5 | -23.09 | -19.99 | -19.39 | -18.89 | -18.38 | -17.47 | -16.17 | -15.12 | -14.66 | -14.61 | -14.65 | -14.61 | -14.07 |
EPS (Diluted) | -12.64 | -17.84 | -21.9 | -25.08 | -25.5 | -23.09 | -19.99 | -19.39 | -18.89 | -18.38 | -17.47 | -16.17 | -15.12 | -14.66 | -14.61 | -14.65 | -14.61 | -14.07 |
EBITDA | -266.74M | -376.15M | -450.12M | -502.65M | -494.76M | -429.49M | -360.39M | -336.4M | -320.88M | -307.94M | -290.92M | -271.32M | -254.75M | -246.47M | -241.93M | -236.87M | -232.54M | -221.19M |
EBIT | -268.16M | -377.46M | -451.22M | -503.53M | -495.48M | -430.06M | -360.92M | -336.92M | -321.38M | -308.43M | -291.39M | -271.76M | -255.17M | -246.87M | -242.33M | -237.28M | -232.97M | -221.65M |
Depreciation & Amortization | 1.42M | 1.31M | 1.1M | 875K | 712K | 571K | 527K | 514K | 500K | 484K | 467K | 444K | 420K | 399K | 405K | 415K | 433K | 459K |